Shire Wins Dismissal Of Generic Adderall Antitrust Suit

Law360, Los Angeles (August 16, 2013, 9:18 PM ET) -- A California federal judge on Friday threw out a putative class action alleging drug company Shire LLC stifled competition for the drug Adderall XR through patent settlements and supply agreements with generic-drug makers, chastising the plaintiff's attorneys for missing a deadline for amending the allegations.

U.S. District Judge Mariana R. Pfaelzer said counsel for Erin Shaffer could file a motion for leave to amend the complaint, meanwhile stating that she would not tolerate any future procedural errors. Attorneys with Milstein Adelman LLP and Kanner & Whiteley...
To view the full article, register now.